Cycloheptyl CP 55,940

Cycloheptyl CP 55,940 is a synthetic cannabinoid which mimics the effects of naturally occurring cannabinoids such as THC. It was developed by the pharmaceutical company Pfizer in the 1970s.

Chemistry

Cycloheptyl CP 55,940 is a derivative of cannabinol, a metabolite of tetrahydrocannabinol (THC). It is a non-selective agonist at the CB1 receptor and CB2 receptor, the two main cannabinoid receptors in the body.

Pharmacology

Cycloheptyl CP 55,940 has similar effects to THC, but is much more potent. It has been used in scientific research to study the effects of cannabinoids on the body and brain. It has been found to have analgesic effects, and may also have anti-inflammatory and neuroprotective effects.

Legal status

In the United States, Cycloheptyl CP 55,940 is a Schedule I controlled substance, meaning it has a high potential for abuse and no accepted medical use. It is also controlled under similar laws in many other countries.

See also

• Cannabinoid receptor
• Cannabinoid
• Tetrahydrocannabinol